|
Volumn 112, Issue 6, 2005, Pages 1170-1171
|
Uniocular drug trial [3] (multiple letters)
a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIGLAUCOMA AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
LATANOPROST;
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING;
CORRELATION COEFFICIENT;
DRUG EFFICACY;
DRUG SCREENING;
HUMAN;
INTRAOCULAR PRESSURE;
LETTER;
LINEAR REGRESSION ANALYSIS;
MEDICAL ASSESSMENT;
OPEN ANGLE GLAUCOMA;
PREDICTION;
PRIORITY JOURNAL;
REGRESSION ANALYSIS;
VARIANCE;
VISUAL FIELD;
CLINICAL TRIAL;
CLOSED ANGLE GLAUCOMA;
DRUG EFFECT;
HEMISPHERIC DOMINANCE;
INTRAOCULAR HYPERTENSION;
NOTE;
OCULOPLETHYSMOGRAPHY;
ANTIHYPERTENSIVE AGENTS;
CLINICAL TRIALS;
FUNCTIONAL LATERALITY;
GLAUCOMA, ANGLE-CLOSURE;
GLAUCOMA, OPEN-ANGLE;
HUMANS;
INTRAOCULAR PRESSURE;
OCULAR HYPERTENSION;
TONOMETRY, OCULAR;
|
EID: 20444388347
PISSN: 01616420
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ophtha.2004.11.022 Document Type: Letter |
Times cited : (2)
|
References (4)
|